In Vitro Diagnostics Business Outlook: Volume 2, Issue 1 - Immunoassay Overview
27 Oct 2022
Categories:
In Vitro Diagnostics Business Outlook
A new twice-monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook offers the following:
• Market Sizing and Forecasting of IVD Market Segments in Every Issue
• Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About
• Industry Watch – Developments with COVID-19 and Other Testing
• M&A, Distribution, Partnerships Tracked and Charted
• New Product Introductions and Company Announcements
• Company Profiling and Quarterly Results Summaries
• Regional Market Coverage
Table of Contents
-
Market Analysis
- Overview of IVD Immunoassay
-
Market Outlook
- Major Product Activity
-
Company Briefs
- Abbott Diagnostics
- Roche
- Siemens Healthineers
-
Executive News Briefing
-
Briefs
- OpGen Closes $3.38 Million in Direct Offering
- Cue Health Appoints New CCO
- Pleno Receives $40 million in Series A
- Exact Sciences’ Revenues Supported by Screening Revenues
- Sekisui Chemical Reports Double Digit Growth in All Business Segments During Q1 FY22
-
Briefs
-
Diagnostic Market Mergers, Acquisitions and Partnership Deals
- Mergers and Acquisitions
- Partnerships and Collaborations
-
Industry Watch
- Virus Testing Update
-
Region Watch
- Italy
- New Zealand
- Singapore
-
Broad-based Company Announcements
- Biocartis Commercializes HepatoPredict Test in Europe
- Fujirebio Markets Self-Screening Cervical Cancer Test in Europe
- Thermo Fisher Launches TaqPath Enteric Bacterial Select Panel
- More Newsletters from Science and Medicine Group